CD4 and breast cancer: In patients with aggressive breast cancers, these pDC exhibit suppressed IFN-α secretion and are able to sustain CD4+ Treg expansion (136), and the suppression of IFN-α production by pDC has been attributed to tumor-derived TGFβ and TNFα mediated-signaling in these cells (137).